 |
|
(SOO-ber-oyl-AN-ih-lide hy-drok-SA-mik A-sid)
| | A drug that is used to treat cutaneous T-cell lymphoma that does not get better, gets worse, or comes back during or after treatment with other drugs. It is also being studied in the treatment of other types of cancer. Suberoylanilide hydroxamic acid is a type of histone deacetylase inhibitor. Also called SAHA, vorinostat, and Zolinza. |
| Previous Definitions: | SU5416, SU6668, subcutaneous, subcutaneous port, subependymal | | Next Definitions: | subglottis, subjective improvement, submucosa, subserosa, subset analysis |
|
|
